SCHEMBL91654

SCHEMBL91654

C=Cc1ccc2cc(C(=O)OCOC3Cc4ccccc4C3)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.39
DRD3 P35462 1/20 0.38
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
KDM4E B2RXH2 3/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.35
EGFR P00533 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
PKM P14618 1/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
JAK1 P23458 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL71690 0.88 TAS1R3 (0.39) MAPTKMT2AALDH1A1MEN1CYP3A4
SCHEMBL91649 0.80 TAS1R3 (0.47) HRH3KDM4EMAPTHPGDKMT2A
SCHEMBL16329467 0.73 CA12 (0.51) KDM4EMAPTKMT2AALDH1A1MEN1
SCHEMBL24611299 0.71 HRH3 (0.40) HRH3DRD3ADRB2ADRB1ADRB3
SCHEMBL30935750 0.69 NPC1 (0.49) HRH3DRD3ADRB2ADRB1ADRB3
SCHEMBL26497867 0.69 NPC1 (0.49) HRH3DRD3ADRB2ADRB1ADRB3
SCHEMBL71831 0.69 CYP3A4 (0.40) HRH3ADRB2ADRB1ADRB3KDM4E
SCHEMBL9610298 0.69 MTNR1A (0.35) HRH3KDM4EMAPTHPGDKMT2A
SCHEMBL4590567 0.69 PTPN11 (0.53) KDM4EMAPTHPGDKMT2AALDH1A1
SCHEMBL12376761 0.69 HRH3 (0.38) HRH3DRD3ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129086-B2 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-8129086-B2 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090297979-A1 Polymerizable compound, polymer, positive resist composition, and patterning process using the same PRRC2A, PUF60, POLR2B HRH3 533/4885DRD3 1892/4885ADRB2 4731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.